menu search

SVRA / Savara to Present at the Jefferies Healthcare Conference

Savara to Present at the Jefferies Healthcare Conference
AUSTIN, Texas--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will participate in a fireside chat at the Jefferies Healthcare Conference on June 9, 2023 at 10:30 am ET/7:30 am PT. A live webcast of the fireside chat will be available on Savara's website at www.savarapharma.com/investors/events-presentations/ and will be archived for 90 days. About Savara Savara is a clinical s. Read More
Posted: Jun 2 2023, 08:05
Author Name: Business Wire
Views: 080845

SVRA News  

Savara: A Speculative Play

By Seeking Alpha
July 16, 2023

Savara: A Speculative Play

Today, we circle back on a small development firm called Savara for the first time in over two years. Its primary drug candidate is being developed fo more_horizontal

Savara to Present at the Jefferies Healthcare Conference

By Business Wire
June 2, 2023

Savara to Present at the Jefferies Healthcare Conference

AUSTIN, Texas--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today ann more_horizontal

Why Shares of Savara Jumped on Tuesday

By The Motley Fool
May 16, 2023

Why Shares of Savara Jumped on Tuesday

Savara is a clinical-stage pharmaceutical company with no revenue. The company expects a top-line readout on molgramostim in the second quarter of 202 more_horizontal

Savara to Present at the Oppenheimer 33rd Annual Healthcare Conference

By Business Wire
March 6, 2023

Savara to Present at the Oppenheimer 33rd Annual Healthcare Conference

AUSTIN, Texas--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today ann more_horizontal

Why Shares of Savara Soared This Week

By The Motley Fool
January 27, 2023

Why Shares of Savara Soared This Week

The clinical-stage biopharmaceutical company focuses on therapies to treat rare respiratory diseases. more_horizontal


Search within

Pages Search Results: